Skip to content
Riskpilot
← Back to search
Sign in
Get full access
ZeMac histoanalys AB
AB
In liquidation
Org 5568292170
Research and experimental development on biotechnology
· NACE 7211
Est. 2010
1 employees
Watchlist
Share
Sweden
/
Companies
/
Research and experimental development on biotechnology
/
ZeMac histoanalys AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2017
1M
2018
1M
2019
1M
2020
0M
2021
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2017
0M
2018
0M
2019
0M
2020
0M
2021
Income statement
SEK thousands
Item
2017
2018
2019
2020
2021
Revenue
398
536
663
514
471
Staff expenses
—
—
—
—
—
EBITDA
−55
45
95
−117
10
Depreciation & amort.
−0
−0
−0
−0
−0
EBIT
−55
45
95
−117
10
Net financials
−4
−1
—
—
—
Profit before tax
−59
44
95
−117
10
Tax
−0
−0
−20
−0
1
Net profit
−59
44
75
−117
11
Balance sheet
SEK thousands
Item
2017
2018
2019
2020
2021
Total assets
58
170
310
117
155
Equity
−17
27
101
−16
−4
Long-term debt
14
0
0
0
0
Short-term debt
60
143
209
133
159
Total debt
74
143
209
133
159
Financial ratios
5-year trend
EBITDA margin
2.1%
This company
15.8%
Market median
-87% vs market
2017
2021
Equity ratio
-2.6%
This company
38.2%
Market median
-107% vs market
2017
2021
Return on equity
1100000.0%
This company
18.4%
Market median
+5978161% vs market
2017
2021
Net profit margin
2.3%
This company
8.1%
Market median
-72% vs market
2017
2021
Asset turnover
3.04×
This company
1.12×
Market median
+171% vs market
2017
2021
Debt / equity
39.75×
This company
0.62×
Market median
-6311% vs market
2017
2021
Annual reports & filings
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
Annual report 2019
Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
View
PDF
Annual report 2018
Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
View
PDF
Annual report 2017
Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
View
PDF
More on ZeMac histoanalys AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
